奧泰生物(688606.SH):子公司擬與關聯方共同對瑞測生物、逸樂生物進行投資
格隆匯12月3日丨奧泰生物(688606.SH)公佈,為豐富公司產品線(如食品安全檢測,農產品安全檢測,畜牧產品相關檢測等),利用公司技術優勢,協同創新,進一步完善公司業務佈局,拓寬國內市場,提升公司綜合競爭力,公司全資子公司賽業科技與關聯方賽創投資擬以現金方式共同對杭州瑞測生物技術有限公司進行投資,投資完成後,註冊資本為2000萬元。
其中賽業科技持股比例為15%,擬認繳出資額人民幣為300萬元,賽創投資持股比例為5%,擬認繳出資額人民幣為100萬元。
為積極拓展公司經營空間,開展技術協同,壯大公司品牌隊伍,豐富公司的銷售渠道,同時打造公司新的利潤增長點,公司全資子公司賽業科技與關聯方賽創投資擬以現金方式共同對杭州逸樂生物技術有限公司進行增資,增資完成後,註冊資本為1000萬元。
其中賽業科技持股比例為20%,擬認繳出資金額人民幣為200萬元,賽創投資持股比例為8%,擬認繳出資額人民幣為80萬元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.